Lactated Ringer's and 5% Dextrose Injection — Class I drug recall D-262-2013
Terminated recall by Hospira Inc., reported 2013-04-24, distributed nationwide. Non-Sterility: Confirmed customer complaint of product contaminated with mold.
| Recall number | D-262-2013 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2013-01-25 |
| Classified | 2013-04-17 |
| Reported by FDA | 2013-04-24 |
| Terminated | 2015-08-21 |
| Distributed | Nationwide (US) |
| Quantity | 143,136 flexible |
| Reason classes | microbial contamination, sterility |
| Pathogens | mold |
| NDC | 00409-7929-09 |
| Expiration dates | 2013-05-01 |
Product
Lactated Ringer's and 5% Dextrose Injection, USP, 1000 mL flexible container, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA; NDC 0409-7929-09.
Reason for recall
Non-Sterility: Confirmed customer complaint of product contaminated with mold.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-262-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.